EUVIMEDEUVIMED entdecken
Crossref

Astragalus polysaccharides alleviate cantharidin-induced liver injury by inhibiting the S100A8/A9-mediated TLR4/NF-κB inflammatory pathway

Wenchao Tang, Qin Shen, Xingyan Du, Jia Yu, Zongge Sa, Yuanyuan Xiao

Phytomedicine · 2026-09 · 159 · 158592

DOI: 10.1016/j.phymed.2026.158592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Wenchao Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. Electronic address: tangdada1990@126.com. Hauptthemen laut MEDLINE: Cantharidin, Calgranulin A, Calgranulin B, Polysaccharides. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cantharidin (CTD), a potent anti-tumor compound from traditional medicine, has its clinical application restricted by severe hepatotoxicity. Astragalus polysaccharides (APS), the primary active components of the food-medicine homologous herb Astragalus membranaceus, are recognized for their hepatoprotective properties. PURPOSE: This study aimed to elucidate the molecular mechanism by which APS protects against CTD-induced liver injury. METHODS: In vivo and in vitro models of CTD-induced liver injury were established. The protective effects of APS were evaluated by serum biochemistry, histopathology, and ultrastructural observation. RNA-sequencing was employed to screen for key targets, which were subsequently validated using qRT-PCR, Western blot, and immunohistochemistry. The cellular origin of S100A8/A9 was identified by immunofluorescence co-localization. The functional role of S100A8/A9 was confirmed via siRNA-mediated gene knockdown. The effect of APS on the anti-tumor activity of CTD was evaluated in human hepatocellular carcinoma cell lines HepG2 and Huh7. RESULTS: APS (characterized by a weight-average molecular weight of 35.002 kDa) ameliorated CTD-induced liver injury, reducing biochemical markers and histopathological damage. RNA-seq identified S100A8/A9 as key targets whose CTD-induced upregulation was reversed by APS. Mechanistically, APS significantly inhibited CTD-induced neutrophil and macrophage infiltration in the liver, and immunofluorescence co-localization confirmed that the elevated S100A8/A9 was mainly derived from infiltrating neutrophils. APS downregulated S100A8/A9 expression, thereby inhibiting the TLR4/NF-κB pathway and the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Critically, S100A8/A9 knockdown confirmed their pivotal role in the inflammatory response and demonstrated a synergistic protective effect when combined with APS. Importantly, APS did not impair the anti-proliferative and pro-apoptotic effects of CTD on human hepatocellular carcinoma cells; instead, it exhibited synergistic anti-tumor activity with CTD in HepG2 cells. CONCLUSION: APS alleviates CTD-induced hepatotoxicity by downregulating the S100A8/A9-mediated TLR4/NF-κB inflammatory cascade, primarily through inhibiting neutrophil recruitment. Furthermore, APS enhances rather than compromises the anti-tumor efficacy of CTD in vitro. These findings support the development of APS as a therapeutic adjuvant to enhance the safety of CTD-based chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CantharidinCalgranulin ACalgranulin BPolysaccharidesAstragalus PlantChemical and Drug Induced Liver InjuryHumansAnimalsToll-Like Receptor 4NF-kappa BMaleHep G2 CellsSignal TransductionLiverMiceCell Line, TumorLiver Neoplasms

Stichwörter der Autor:innen

Astragalus polysaccharidesCantharidinLiver injuryNF-κB pathwayS100A8/A9

Substanzen

CantharidinCalgranulin ACalgranulin BPolysaccharidesToll-Like Receptor 4NF-kappa BS100A9 protein, humanS100A8 protein, humanTLR4 protein, human

Autor:innen und Institutionen

  • School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. Electronic address: tangdada1990@126.com.
  • School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
  • The First Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, 550001, China.
  • School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; School of Health Preservation and Rehabilitation, Guizhou University of Traditional Chinese Medicine, Guiyang 550025,…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tang, W., Shen, Q., Du, X., Yu, J., Sa, Z., & Xiao, Y. (2026). Astragalus polysaccharides alleviate cantharidin-induced liver injury by inhibiting the S100A8/A9-mediated TLR4/NF-κB inflammatory pathway. Phytomedicine, 159, 158592. https://doi.org/10.1016/j.phymed.2026.158592

Vancouver

Tang W, Shen Q, Du X, Yu J, Sa Z, Xiao Y. Astragalus polysaccharides alleviate cantharidin-induced liver injury by inhibiting the S100A8/A9-mediated TLR4/NF-κB inflammatory pathway. Phytomedicine. 2026;159:158592. doi:10.1016/j.phymed.2026.158592

BibTeX
@article{Tang2026,
  author = {Tang, Wenchao and Shen, Qin and Du, Xingyan and Yu, Jia and Sa, Zongge and Xiao, Yuanyuan},
  title = {Astragalus polysaccharides alleviate cantharidin-induced liver injury by inhibiting the S100A8/A9-mediated TLR4/NF-κB inflammatory pathway},
  journal = {Phytomedicine},
  year = {2026},
  volume = {159},
  pages = {158592},
  doi = {10.1016/j.phymed.2026.158592}
}
Kostenlos starten →